Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism

NACompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

October 19, 2022

Primary Completion Date

January 4, 2024

Study Completion Date

January 4, 2024

Conditions
Pulmonary EmbolismAcute Pulmonary Embolism
Interventions
DEVICE

AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE

The AngioDynamics' AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE has five main components, a flexible cannula (F1885), sheath, tapered obturator, aspirator handle, and waste bag.

Trial Locations (25)

10032

Columbia University Medical Center/NYPH, New York

10461

Jacobi Medical Center, The Bronx

14203

University of Buffalo, Buffalo

15219

UPMC Pittsburgh, Pittsburgh

16550

UPMC Hamot, Erie

19403

Einstein Medical Center, Montgomery

30303

Emory University at Grady Memorial Hospital, Atlanta

30309

Piedmont Heart Institute, Atlanta

32216

HCA Memorial Hospital Jacksonville, Jacksonville

37934

Tennova Healthcare -Turkey Creek Medical Center, Knoxville

43221

Ohio State University Wexner Medical Center, Columbus

45342

Kettering Health, Miamisburg

46321

Community Hospital, Munster

47405

Indiana University, Indianapolis

53215

Aurora Health Care, Milwaukee

56303

CentraCare Heart and Vascular Center, Saint Cloud

61611

OSF Healthcare, Peoria

70121

Oshner Medical Center, Jefferson

75226

Baylor Heart and Vascular Hospital, Dallas

77030

Memorial Hermann (University of Texas at Houston), Houston

78229

Methodist Hospital, San Antonio

85258

HonorHealth, Scottsdale

90404

UCLA Health, Los Angeles

06519

Yale University, New Haven

07103

Rutgers University, Newark

Sponsors
All Listed Sponsors
lead

Angiodynamics, Inc.

INDUSTRY

NCT05318092 - Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism | Biotech Hunter | Biotech Hunter